Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
China flag China · Delayed Price · Currency is CNY
15.77
+0.43 (2.80%)
Feb 4, 2026, 3:04 PM CST

SHE:300452 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Net Income
129.56119.42161.54130.7189.2593.94
Depreciation & Amortization
50.6950.6938.7836.0634.6831.76
Other Amortization
0.480.480.280.13--
Loss (Gain) From Sale of Assets
-0.11-0.110.010.270.120.55
Asset Writedown & Restructuring Costs
39.1339.131.020.018.971.31
Loss (Gain) From Sale of Investments
-16.25-16.25-19.05-5.11-7.83-4.2
Provision & Write-off of Bad Debts
-0-00.05-0.04-0.01-0.17
Other Operating Activities
80.2111.957.04-1.13-2.231.17
Change in Accounts Receivable
-96.59-96.59-42.25-98.58-28.04-48.23
Change in Inventory
5.345.34-2.91-13.43-28.91-2.31
Change in Accounts Payable
-3.27-3.27-15.1277.6336.8611.62
Change in Other Net Operating Assets
0.070.070.260.93.840.43
Operating Cash Flow
196.72118.33132.3132.82103.8285.55
Operating Cash Flow Growth
79.21%-10.56%-0.39%27.93%21.36%7.65%
Capital Expenditures
-38.8-27.94-54.92-67.31-31.47-21.36
Sale of Property, Plant & Equipment
0.740.550.10.690.55-
Investment in Securities
9-7-288.69-29.315-69
Other Investing Activities
10.1319.3810.547.736.083.47
Investing Cash Flow
-18.93-15.01-332.98-88.21-19.84-86.89
Short-Term Debt Issued
-14.85-49.831.1549.09
Long-Term Debt Issued
-32.22338.88---
Total Debt Issued
30.8747.08338.8849.831.1549.09
Short-Term Debt Repaid
----41-40.1-20.22
Long-Term Debt Repaid
--50.52-49.57---
Total Debt Repaid
-47.76-50.52-49.57-41-40.1-20.22
Net Debt Issued (Repaid)
-16.89-3.44289.318.8-8.9528.87
Issuance of Common Stock
-----20.08
Repurchase of Common Stock
-22.51-22.51----
Common Dividends Paid
-66.96-59.01-59.78-55.33-46.32-35.07
Other Financing Activities
22.26-0.25-1.36-1.99--5.12
Financing Cash Flow
-84.09-85.21228.17-48.52-55.278.76
Foreign Exchange Rate Adjustments
1.031.22-0.012.56-0.28-1
Net Cash Flow
94.7219.3327.47-1.3528.436.42
Free Cash Flow
157.9290.3977.3865.572.3564.19
Free Cash Flow Growth
92.17%16.82%18.13%-9.46%12.71%226.94%
Free Cash Flow Margin
16.89%10.24%9.22%9.30%11.73%12.08%
Free Cash Flow Per Share
0.660.390.320.280.310.28
Cash Income Tax Paid
58.0658.7215.4740.4640.4238.13
Levered Free Cash Flow
132.2425.8953.49114.8845.7941.73
Unlevered Free Cash Flow
140.0333.8556.18115.6446.5442.19
Change in Working Capital
-86.99-86.99-57.37-28.09-19.13-38.82
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.